EPHX1 and lung carcinoma: In conclusion, the results of this Austrian Caucasian study support the hypothesis that genetically reduced mEH activity may be protective against lung cancer, especially for adenocarcinoma, as we found a statistically significant reduced risk for individuals homozygous for the exon 3 variant allele.